SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

The prognostic value of interim positron emission tomography (PET) interpreted according to visual criteria is a matter of debate in diffuse large B-cell lymphoma (DLBCL). Maximal standardized uptake value reduction (ΔSUVmax) may better predict outcome. To compare the prognostic value of both method...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2011-07, Vol.118 (1), p.37-43
Main Authors: Casasnovas, René-Olivier, Meignan, Michel, Berriolo-Riedinger, Alina, Bardet, Stéphane, Julian, Anne, Thieblemont, Catherine, Vera, Pierre, Bologna, Serge, Brière, Josette, Jais, Jean-Philippe, Haioun, Corinne, Coiffier, Bertrand, Morschhauser, Franck
Format: Article
Language:English
Subjects:
Adolescent
Adult
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Bleomycin - therapeutic use
Cyclophosphamide - therapeutic use
Doxorubicin - therapeutic use
Female
Fluorodeoxyglucose F18
Hematologic and hematopoietic diseases
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma, Large B-Cell, Diffuse - diagnostic imaging
Lymphoma, Large B-Cell, Diffuse - drug therapy
Male
Medical sciences
Middle Aged
Positron-Emission Tomography - methods
Predictive Value of Tests
Prednisone - therapeutic use
Prognosis
Prospective Studies
Radiopharmaceuticals
Rituximab
Vincristine - therapeutic use
Vindesine - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!